(CPRI) Capri Holdings - Ratings and Ratios
Handbags, Footwear, Apparel, Accessories, Fragrances
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 39.5% |
| Value at Risk 5%th | 51.3% |
| Relative Tail Risk | -20.92% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.30 |
| Alpha | -24.88 |
| CAGR/Max DD | -0.33 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.418 |
| Beta | 2.137 |
| Beta Downside | 1.822 |
| Drawdowns 3y | |
|---|---|
| Max DD | 81.75% |
| Mean DD | 50.31% |
| Median DD | 48.73% |
Description: CPRI Capri Holdings January 14, 2026
Capri Holdings Ltd (NYSE: CPRI) designs, markets, and distributes luxury apparel, footwear, and accessories across four continents, operating under the Versace, Jimmy Choo, and Michael Kors brands. Its product mix includes ready-to-wear, handbags, watches, jewelry, fragrances, and home furnishings, sold through owned boutiques, department and specialty stores, and growing e-commerce channels.
In FY 2023 the company generated roughly $5.5 billion in revenue, with an operating margin of about 12% and e-commerce accounting for ~30% of total sales-a figure that has risen ~8 percentage points year-over-year, reflecting the broader luxury sector’s digital shift. Headwinds include exposure to a strong U.S. dollar and uneven consumer confidence in Europe, while upside drivers are robust demand for luxury goods in China and the Middle East, and the ongoing rollout of sustainable product lines.
For a deeper quantitative view of CPRI’s valuation metrics, you might explore the analyst tools on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-1.17b TTM) > 0 and > 6% of Revenue (6% = 236.9m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -4.20pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 4.68% (prev -2.95%; Δ 7.63pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 190.0m > Net Income -1.17b (YES >=105%, WARN >=100%) |
| Net Debt (2.94b) to EBITDA (229.0m) ratio: 12.83 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.14 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (119.8m) change vs 12m ago 0.85% (target <= -2.0% for YES) |
| Gross Margin 62.47% (prev 63.26%; Δ -0.78pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 65.79% (prev 61.43%; Δ 4.36pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 9.0 (EBITDA TTM 229.0m / Interest Expense TTM 8.00m) >= 6 (WARN >= 3) |
Altman Z'' 3.94
| (A) 0.04 = (Total Current Assets 1.52b - Total Current Liabilities 1.34b) / Total Assets 5.21b |
| (B) 0.82 = Retained Earnings (Balance) 4.30b / Total Assets 5.21b |
| warn (B) unusual magnitude: 0.82 — check mapping/units |
| (C) 0.01 = EBIT TTM 72.0m / Avg Total Assets 6.00b |
| (D) 0.90 = Book Value of Equity 4.35b / Total Liabilities 4.84b |
| Total Rating: 3.94 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 27.45
| 1. Piotroski 3.0pt |
| 2. FCF Yield 1.10% |
| 3. FCF Margin 1.65% |
| 4. Debt/Equity 8.43 |
| 5. Debt/Ebitda 12.83 |
| 6. ROIC - WACC (= -3.90)% |
| 7. RoE -261.2% |
| 8. Rev. Trend -79.53% |
| 9. EPS Trend -63.46% |
What is the price of CPRI shares?
Over the past week, the price has changed by -3.07%, over one month by -1.23%, over three months by +11.19% and over the past year by +2.84%.
Is CPRI a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 12
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CPRI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 28.1 | 12.5% |
| Analysts Target Price | 28.1 | 12.5% |
| ValueRay Target Price | 22 | -11.9% |
CPRI Fundamental Data Overview January 19, 2026
P/S = 0.6774
P/B = 2.8996
P/EG = 0.8338
Revenue TTM = 3.95b USD
EBIT TTM = 72.0m USD
EBITDA TTM = 229.0m USD
Long Term Debt = 1.75b USD (from longTermDebt, last quarter)
Short Term Debt = 374.0m USD (from shortTermDebt, last quarter)
Debt = 3.10b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.94b USD (from netDebt column, last quarter)
Enterprise Value = 5.90b USD (2.96b + Debt 3.10b - CCE 166.0m)
Interest Coverage Ratio = 9.0 (Ebit TTM 72.0m / Interest Expense TTM 8.00m)
EV/FCF = 90.72x (Enterprise Value 5.90b / FCF TTM 65.0m)
FCF Yield = 1.10% (FCF TTM 65.0m / Enterprise Value 5.90b)
FCF Margin = 1.65% (FCF TTM 65.0m / Revenue TTM 3.95b)
Net Margin = -29.55% (Net Income TTM -1.17b / Revenue TTM 3.95b)
Gross Margin = 62.47% ((Revenue TTM 3.95b - Cost of Revenue TTM 1.48b) / Revenue TTM)
Gross Margin QoQ = 60.98% (prev 62.99%)
Tobins Q-Ratio = 1.13 (Enterprise Value 5.90b / Total Assets 5.21b)
Interest Expense / Debt = 0.26% (Interest Expense 8.00m / Debt 3.10b)
Taxrate = 21.0% (US default 21%)
NOPAT = 56.9m (EBIT 72.0m * (1 - 21.00%))
Current Ratio = 1.14 (Total Current Assets 1.52b / Total Current Liabilities 1.34b)
Debt / Equity = 8.43 (Debt 3.10b / totalStockholderEquity, last quarter 368.0m)
Debt / EBITDA = 12.83 (Net Debt 2.94b / EBITDA 229.0m)
Debt / FCF = 45.18 (Net Debt 2.94b / FCF TTM 65.0m)
Total Stockholder Equity = 446.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -19.44% (Net Income -1.17b / Total Assets 5.21b)
RoE = -261.2% (Net Income TTM -1.17b / Total Stockholder Equity 446.8m)
RoCE = 3.27% (EBIT 72.0m / Capital Employed (Equity 446.8m + L.T.Debt 1.75b))
RoIC = 2.93% (NOPAT 56.9m / Invested Capital 1.94b)
WACC = 6.84% (E(2.96b)/V(6.06b) * Re(13.79%) + D(3.10b)/V(6.06b) * Rd(0.26%) * (1-Tc(0.21)))
Discount Rate = 13.79% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.42%
[DCF Debug] Terminal Value 78.82% ; FCFF base≈187.0m ; Y1≈144.3m ; Y5≈91.0m
Fair Price DCF = N/A (negative equity: EV 2.17b - Net Debt 2.94b = -767.2m; debt exceeds intrinsic value)
EPS Correlation: -63.46 | EPS CAGR: -4.84% | SUE: -0.47 | # QB: 0
Revenue Correlation: -79.53 | Revenue CAGR: -15.49% | SUE: 0.10 | # QB: 0
EPS current Year (2026-03-31): EPS=1.37 | Chg30d=+0.012 | Revisions Net=+2 | Growth EPS=+136.4% | Growth Revenue=-22.3%
EPS next Year (2027-03-31): EPS=1.84 | Chg30d=+0.027 | Revisions Net=+2 | Growth EPS=+34.5% | Growth Revenue=+2.1%
Additional Sources for CPRI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle